Seroprevalence of Parvovirus B19 in Immunocompromised ICU Patients in Western Colombia
Abstract
Human parvovirus B19 (B19) is a pathogen that primarily infects erythroid and other cell types due to its binding to the P globoside antigen. The seroprevalence of anti-B19 IgG varies with age, ranging from 2-15% in children to over 85% in older adults. B19 can cause a wide range of clinical manifestations, including erythema infectiosum (fifth disease) in children and pure red cell aplasia in immunocompromised individuals, particularly those with HIV, oncology or autoimmune diseases. The aim of this study was to determine the seroprevalence of IgM, IgG, and IgG avidity against B19 in immunocompromised patients hospitalized in two health institutions in Valle del Cauca, Colombia. A total of 104 immunocompromised patients hospitalized in intensive care units at two institutions in Valle del Cauca, Colombia, were enrolled in this study. Blood samples were collected and analyzed by immunoassay to determine the seroprevalence of IgM, IgG, and IgG avidity specific for B19. Statistical analysis was performed to assess the relationship between B19 seroprevalence and variables such as age, chronic non-communicable diseases, acquired immunodeficiencies, and severe anemic syndrome. The study showed a seroprevalence of 66.35% for IgG anti-B19 in immunocompromised patients. A statistically significant correlation was found between B19 seroprevalence and the presence of chronic non-communicable diseases (p = 0.000) and acquired immunodeficiencies (p = 0.018). There was also a significant association between seropositivity and severe anemic syndrome (p < 0.000) and patient age (p = 0.009). This study is the first to document B19 seroprevalence in immunocompromised patients in Colombia and highlights a significant association with specific immunosuppressive conditions, such as chronic non-communicable diseases and acquired immunodeficiencies. The findings highlight the importance of monitoring B19 infection in these vulnerable populations, particularly given its association with severe anemia and other critical conditions.
Keywords: Seroprevalence; immunocompromised patients; anemia; human parvovirus B19.
Full Text:
PDFReferences
PLÜMERS R, DREIER J, KNABBE C, & VOLLMER T. Unexpected high incidence of parvovirus B19 nucleic acid detection in German blood donors in the winter/spring season 2023/2024. Journal of Medical Virology, 2024, 96(9): e29878. https://doi.org/10.1002/jmv.29878.
CHIRAMBO-KALOLEKESHA M, KAILE T, MWABA F, DAKA V, SIMAKANDO M, & KOWA S. Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV/AIDS at the Kitwe Central Hospital, blood bank. African Health Sciences, 2018; 18: 496. https://doi.org/10.4314/ahs.v18i3.5.
BIERI J, LEISI R, BIRCHER C, & ROS C. Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking. PLoS Pathogens, 2021, 17: e1009434. https://doi.org/10.1371/journal.ppat.1009434.
KUMARI S, KURUVILLA THOMAS R, SRUTHI S, BARANI R, SANGVI S, KRISHNAMOORTHY R, & SRIKANTH, P. Increased parvovirus B19 seropositivity in healthy blood donors in India. Scientific Reports, 2024, 14: 20497. https://doi.org/10.1038/s41598-024-68095-2
ASHAKA S.O, BABALOLA SALU O, BABATUNDE JAMES A, ORIOWO BOLA OYEFOLU A, ADEYEMI ANJORIN A, OLUDARE OKE B, … OMILABU S.A. Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study. African Health Sciences, 2020, 20: 219–226. https://doi.org/10.4314/ahs.v20i1.27
CLAVER BELVER N, SANFELIU SALA I, MERINO ASENSIO MJ, MONTERDE PEDRA C, PINEDA SOLAS V, CAPILLA RUBIO S, … & AYMERICH D.F. Erythrovirus B19 infections. Six years of follow-up in adults and children. Anales de Pediatria (Engl Ed) 2019, 90: 280–284. https://doi.org/10.1016/j.anpedi.2018.05.01
BHATTARAI AM, DHAKAL B, ROKAYA P, KARKI A, GURUNG S, & BARAL S. Aplastic anemia induced by human parvovirus B19 infection in an immunocompetent adult male without prior hematological disorders: A case report. Annals of Medicine & Surgery, 2022, 79: 103998. https://doi.org/10.1016/j.amsu.2022.103998
RINKŪNAITĖ I, ŠIMOLIŪNAS E, BIRONAITĖ D, RUTKIENĖ R, BUKELSKIENĖ V, MEŠKYS R, … & BOGOMOLOVAS J. The Effect of a Unique Region of Parvovirus B19 Capsid Protein VP1 on Endothelial Cells. Biomolecules, 2021, 11: 606. https://doi.org/10.3390/biom11040606
EID AJ, ARDURA MI, & AST INFECTIOUS DISEASES COMMUNITY OF PRACTICE. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice. Clinical Transplantation, 2019, 33(9): e13535. https://doi.org/10.1111/ctr.13535
PARODIS LÓPEZ Y, SANTANA ESTUPIÑÁN R, MARRERO ROBAYNA S, GALLEGO SAMPER R, HENRÍQUEZ PALOP F, RIVERO VERA JC, … & RODRÍGUEZ PÉREZ JC. Anaemia and fever in Kidney transplant. The role of human parvovirus B19. Nefrología, 2017, 37(2): 206–212. https://doi.org/10.1016/j.nefro.2016.08.005
LANDRY ML. Parvovirus B19. Microbiology Spectrum, 2016, 4(3). https://doi.org/10.1128/microbiolspec.DMIH2-0008-2015
GONG L, TIAN J, ZHANG Y, FENG Z, WANG Q, WANG Y, … & HUANG G. Human Parvovirus B19 May Be a Risk Factor in Myasthenia Gravis with Thymoma. Annals of Surgical Oncology, 2023, 30: 1646–1655. https://doi.org/10.1245/s10434-022-12936-9
GUO J, WANG Y, ZHANG M, ZHENG H, ZANG Q, HUANG P, … & MIAO W. Human parvovirus B19 infection in hospitalized patients suspected of infection with pathogenic microorganism. Frontiers in Cellular and Infection Microbiology, 2022, 12: 1083839. https://doi.org/10.3389/fcimb.2022.1083839
NACIUTE M, MIELIAUSKAITE D, RUGIENE R, NIKITENKIENE R, JANCORIENE L, MAURICAS M, & GIRKONTAITE, I. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis. Journal of General Virology, 2016, 97(1): 3302–3312. https://doi.org/10.1099/jgv.0.000621
GANAIE SS, & QIU J. Recent Advances in Replication and Infection of Human Parvovirus B19. Frontiers in Cellular and Infection Microbiology, 2018, 8: 166. https://doi.org/10.3389/fcimb.2018.00166
RENO ML, COX CR, & POWELL EA. Parvovirus B19: a Clinical and Diagnostic Review. Clinical Microbiology Newsletter, 2022, 44: 107–114. https://doi.org/10.1016/j.clinmicnews.2022.06.003
MAKHLOUF MM, ELWAKIL SG, & IBRAHIM NS. Molecular and serological assessment of parvovirus B-19 infection in Egyptian children with sickle cell disease. Journal of Microbiology, Immunology and Infection, 2017, 50: 565–569. https://doi.org/10.1016/j.jmii.2015.10.016
DOBAÑO C, RAMÍREZ-MORROS A, ALONSO S, RUBIO R, RUIZ-OLALLA G, VIDAL-ALABALL J, … & RUIS-COMELLAS A. Sustained seropositivity up to 20.5 months after COVID-19. BMC Medicine, 2022, 20: 379. https://doi.org/10.1186/s12916-022-02570-3
SAFIYANU MB, AKANDE AO, BABAYO A, UMAR J, & ABDULLAHI IN. Serological detection of human parvovirus B19 infection and associated risk factors among pregnant women in Jigawa State, Nigeria. Journal of Immunoassay and Immunochemistry, 2021, 42: 380–392. https://doi.org/10.1080/15321819.2021.1880435
DE PASCHALE M, PAVIA C, CERULLI T, CAGNIN D, MANCO MT, BELVISI L, & CLERICI P. Prevalence of anti‐parvovirus B19 IgG and IgM and parvovirus B19 viremia in pregnant women in an urban area of Northern Italy. Journal of Medical Virology, 2022, 94: 5409–5414. https://doi.org/10.1002/jmv.27963
ABDELRAHMAN D, AL-SADEQ DW, SMATTI MK, TALEB SA, ABUODEH RO, AL-ABSI ES, … & NASRALLAH GK. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar. Viruses, 2021, 13(4): 540. https://doi.org/10.3390/v13040540
CHIRAMBO-KALOLEKESHA M, KAILE T, MWABA F, DAKA V, SIMAKANDO M, & KOWA S. Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV/AIDS at the Kitwe Central Hospital, blood bank. African Health Sciences, 2018, 18: 496. https://doi.org/10.4314/ahs.v18i3.5
ALSAMARAI AM, HASSAN HM, ALSAMARAI MA, & ALJUMAILI ZK. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk. Anti-inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2021, 20: 359–366. https://doi.org/10.2174/1871523020666210727142351
SIM JY, CHANG L-Y, CHEN J-M, LEE P-I, HUANG L-M, & LU C-Y. Human parvovirus B19 infection in patients with or without underlying diseases. Journal of Microbiology, Immunology and Infection, 2019, 52: 534–541. https://doi.org/10.1016/j.jmii.2019.05.009
XU F, WANG Y, FAN L, HE Y, CHEN X, YE P, … & LI L. Pure Red Cell Aplasia Caused by Parvovirus B19 in Patients with Human Immunodeficiency Virus Infection: A Series of Four Cases. Infectious Diseases & Immunity, 2023, 3(3): 132-135. https://doi.org/10.1097/ID9.0000000000000091
MARTINEZ ROSADO LL, MONTOYA CASTILLO M, & BERLINGHIERI PEREZ JD. Aplasia pura de células rojas secundaria a infección por parvovirus B19 en paciente VIH positivo. Acta Médica Colombiana, 2018, 43: 42–44. https://doi.org/10.36104/amc.2018.1009
MORADZADEH R, & ZAMANIAN M. HIV-Related Stigma Among People Living with HIV in Iran: A Cross-Sectional Study. Journal of the Association of Nurses in AIDS Care, 2021, 32: 610–618. https://doi.org/10.1097/JNC.0000000000000251
YAGHOUBI F, DALIL D, TAVAKOLI F, & HOSSEINI SM. Relapsing anaemia associated with parvovirus B19 infection in a kidney transplant recipient: A case report and review of the literature. Clinical Case Reports, 2023, 11(9): e7906. https://doi.org/10.1002/ccr3.7906
SINGH V, DOGRA PM, SINGH P, SINGH SK, GHOSH I, SREENIVASA S, … & ARYA R. Parvovirus B19 infection after kidney transplantation: A single centre experience. Medical Journal, Armed Forces India 2023, 79(6): 665–671. https://doi.org/10.1016/j.mjafi.2023.08.005
SABANCI M, TAŞDEMIR M, ÖKSÜZ B, ALTUNER TORUN Y, SÜTÇÜ M, & ÖZKAYA O. Managing recurrent parvovirus B19-associated anaemia after a paediatric kidney transplant. Pediatric Nephrology, 2024, 39: 2923–2925. https://doi.org/10.1007/s00467-024-06378-6
NORIEGA-SALAS L, CRUZ-SANTIAGO J, LÒPEZ-LÒPEZ B, DEL ROSARIO GARCIA-RAMIREZ C, & ROBLEDO-MELENDEZ A. Aplastic anaemia associated with parvovirus B19 in living donor kidney transplantation: experience of a reference center. Nefrología (English Edition), 2021, 41: 599–601. https://doi.org/10.1016/j.nefroe.2021.11.005
LINDAHL JP, BARLINN R, ABRAHAMSEN IW, SPETALEN S, MIDTVEDT K, & JENSSEN T. Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone. Frontiers in Medicine (Lausanne), 2022, 9: 849783. https://doi.org/10.3389/fmed.2022.849783
ALTHEABY A, ALOTAIBI M, ALAJLAN N, ALSHAREEF A, ALRUWAYMI M, ABOALSAMH G, … & ARABI Z. Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review. Case Reports in Transplantation, 2021, 2021: 7651488. https://doi.org/10.1155/2021/7651488
VALENCIA PACHECO G, NAKAZAWA UEJI YE, RODRÍGUEZ DZUL EA, ANGULO RAMÍREZ AV, LÓPEZ VILLANUEVA RF, QUINTAL ORTÍZ IG, … & ROSADO PAREDES EP. Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico. Colombia Medica, 2017, 48(3): 105–112. https://doi.org/10.25100/cm.v48i3.2981
CUBEL GARCIA R DE CN, PEREIRA RFA, AZEVEDO KML DE, CASTRO TX DE, MELLO FCA, SETUBAL S, … & OLIVEIRA SA. Molecular diversity of human parvovirus B19 during two outbreaks of erythema infectiosum in Brazil. The Brazilian Journal of Infectious Diseases, 2017, 21: 102–106. https://doi.org/10.1016/j.bjid.2016.11.002
Refbacks
- There are currently no refbacks.
